PATIENT INFORMATION LEAFLET NELABOCIN ... - Pharmathen
PATIENT INFORMATION LEAFLET NELABOCIN ... - Pharmathen
PATIENT INFORMATION LEAFLET NELABOCIN ... - Pharmathen
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
observed after the uptake of food.<br />
The concomitant administration of cephalosporins with<br />
tetracyclines or chloramphenicol is of antagonizing result.<br />
When cefuroxime axetil is administered in large doses<br />
along with nephrotoxic drugs such as aminoglycosides, the<br />
risk of nephrotoxicity increases.<br />
2.6 Posology and method of administration<br />
Cefuroxime axetil should be taken after meals, so as for<br />
greater absorption to be reached.<br />
Adults: Most infections respond to 250mg twice daily.<br />
Urinary infections: A dose of 125mg twice daily is usually<br />
enough. In pyelonephritis, the recommended dose is<br />
250mg twice daily.<br />
Infections of the lower respiratory system of light to mean<br />
severity such as bronchitis:<br />
250mg twice daily.<br />
More severe infections of the lower respiratory system or<br />
in the suspicion of pneumonia: 500mg twice daily.<br />
Uncomplicated gonococcal urethritis: 1g once daily.<br />
Patients with renal impairment<br />
The safety and effectiveness of cefuroxime axetil in<br />
patients with renal impairment has not been proved. Since<br />
cefuroxime axetil is excreted by the kidneys, its half- life<br />
shall be prolonged in the case of these patients.<br />
Children: Due to their bitter taste, the cefuroxime axetil<br />
tablets should not be crumbled. They are, therefore, inappropriate<br />
for children under 5.<br />
2.7 Overdosage- Treatment<br />
Cephalosporins’ overdose may cause brain irritation with<br />
potential spasms. The cefuroxime serum level is reduced<br />
by hemodialysis or peritoneal dialysis.<br />
In case of an overdosage please contact your nearest<br />
poisoning centre.2.8 Undesirable effects<br />
The undesirable effects of cefuroxime axetil are generally<br />
mild and transient. As with other cephalosporins,<br />
polymorphis erythema, Stevens-Johnson syndrome, toxic<br />
epidermic necrolysis (exanthematous necrolysis) and<br />
hypersensitivity reactions including skin rash, cnidosis,<br />
itch, pharmaceutical fever, seronosia and anaphylaxis have<br />
rarely been reported. A small percentage of patients who<br />
used cefuroxime axetil developed gastrointestinal disorders<br />
such as diarrhoea, nausea and vomiting. As with other<br />
wide spectrum antibiotics, cases of pseudomembranoid<br />
colitis have been reported. Cephalalgia has also been<br />
reported. Superinfections by the development of resistant<br />
strains may appear. During the cefuroxime axetil treatment,<br />
eosinophilia and a transient increase in the hepatic<br />
enzymes’ levels [ALT(SGPT), AST(SGOT) and LDH] were<br />
observed. As with other cephalosporins, jaundice was<br />
rarely reported.<br />
Dizziness, hallucinations, confusion, itching of the genitals<br />
and vaginitis have also been rarely reported.<br />
In the case of patients receiving cephalosporins, positive<br />
reaction to Coombs test may appear and very rarely<br />
haemolytic anaemia may develop.<br />
Disorders in the blood’s coagulability, leukopenia, neutropenia,<br />
thrombopenia, renal malfunction and toxic<br />
nephropathy may also appear.<br />
2.9 What the patient should do in case of missing<br />
a dose<br />
If you must be receiving the drug continuously and you<br />
miss a dose, you should replace it as soon as possible.<br />
However, if the time for the next dose is near, do not take<br />
the dose you have missed but continue your treatment<br />
normally.<br />
Do not double doses.<br />
2.10 Product expiry date<br />
Inscribed on the external and internal package.<br />
In case this date has passed, do not use the drug.<br />
2.11 Special precautions for storage<br />
Keep at room temperature between 15 – 25 0 C and out of<br />
reach and sight of children.<br />
2.12 Date of last revision of the text<br />
Prot. No.:<br />
3. <strong>INFORMATION</strong> REGARDING THE CORRECT USE<br />
OF DRUGS<br />
- This medicine has been prescribed to you by your doctor<br />
not give it to other people or use it for a different disease,<br />
- If during treatment a problem regarding the drug appears,<br />
immediately notify your doctor or pharmacist.<br />
- If there are any questions regarding the information<br />
related to the drug you receive or if you need to be better<br />
informed for your medical problem, do not hesitate to ask<br />
your doctor of pharmacist.<br />
- In order for the drug administered to you to be effective<br />
and safe, it should be taken according to the given<br />
instructions.<br />
- For your safety and health, it is necessary to carefully<br />
read all information related to the drug.<br />
- Do not keep drugs in bathroom cupboards because heat<br />
and moisture may alter the drug and place it as harmful<br />
for your health.<br />
- Do not keep drugs you no longer need or have expired.<br />
- For greater safety, keep all drugs in a safe place and out<br />
of reach and sight for children.<br />
4. LEGAL CATEGORY<br />
Nelabocin is a Prescription only Medicine.<br />
5. MARKETING AUTHORISATION NUMBER in<br />
Greece<br />
Tablets 250mg : 48063/14-10-2008<br />
Tablets 500mg :48064/14-10-2008